Sudden cardiac death secondary to antidepressant and antipsychotic drugs
- PMID: 18324881
- PMCID: PMC2365731
- DOI: 10.1517/14740338.7.2.181
Sudden cardiac death secondary to antidepressant and antipsychotic drugs
Abstract
A number of antipsychotic and antidepressant drugs are known to increase the risk of ventricular arrhythmias and sudden cardiac death. Based largely on a concern over QT prolongation and the development of life-threatening arrhythmias, a number of antipsychotic drugs have been temporarily or permanently withdrawn from the market or their use restricted. Some antidepressants and antipsychotics have been linked to QT prolongation and the development of Torsade de pointes arrhythmias, whereas others have been associated with a Brugada syndrome phenotype and the development of polymorphic ventricular arrhythmias. This review examines the mechanisms and predisposing factors underlying the development of cardiac arrhythmias, and sudden cardiac death, associated with antidepressant and antipsychotic drugs in clinical use.
Figures
References
-
- Abdelmawla N, Mitchell AJ. Sudden cardiac death and antipsychotics. Part 1. Risk factors and mechanisms. Adv Psychiatr Treat. 2006;12:35–44.
-
- Abdelmawla N, Mitchell AJ. Sudden cardiac death and antipsychotics. Part 2. Monitoring and prevention. Adv Psychiatr Treat. 2006;12:100–9.
-
- Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur Vaiss. 1966;59:263–72. - PubMed
-
- Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–11. - PubMed
-
- Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003;421:634–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical